Tower Research Capital LLC (TRC) - PROTARA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PROTARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,006
+51.5%
4,794
+116.8%
0.00%
Q2 2023$5,2842,211
+1562.4%
0.00%
Q4 2022$0
-100.0%
133
-92.6%
0.00%
Q2 2022$5,000
-16.7%
1,807
+126.2%
0.00%
Q4 2021$6,000
-60.0%
799
-48.4%
0.00%
Q2 2021$15,000
-44.4%
1,548
-10.4%
0.00%
Q1 2021$27,0000.0%1,728
+54.0%
0.00%
-100.0%
Q4 2020$27,000
-12.9%
1,122
-38.6%
0.00%
Q3 2020$31,000
+933.3%
1,828
+1887.0%
0.00%
Q2 2020$3,000920.00%
Other shareholders
PROTARA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,692,594$8,077,8832.42%
Privium Fund Management (UK) Ltd 119,730$401,0960.32%
Ikarian Capital, LLC 188,664$584,8590.13%
Orbimed Advisors 793,558$2,483,8370.05%
Boxer Capital, LLC 209,227$6550.03%
Perceptive Advisors 290,051$907,8600.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 64,000$198,4000.01%
Baker Brothers Advisors 199,671$624,9700.00%
BOOTHBAY FUND MANAGEMENT, LLC 18,864$59,0440.00%
TWO SIGMA INVESTMENTS, LP 35,745$111,8820.00%
View complete list of PROTARA THERAPEUTICS INC shareholders